Topically administered bevacizumab had longer standing anti-angiogenic effect than subconjunctivally injected bevacizumab in rat corneal neovacularization.
about
Attenuation of corneal neovascularization by topical low-molecular-weight heparin-taurocholate 7 without bleeding complicationInhibition of corneal neovascularization by topical and subconjunctival tigecycline.Topical Bevacizumab for the Treatment of Ocular Surface Squamous NeoplasiaTreatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab.Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model
P2860
Topically administered bevacizumab had longer standing anti-angiogenic effect than subconjunctivally injected bevacizumab in rat corneal neovacularization.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Topically administered bevaciz ...... rat corneal neovacularization.
@en
Topically administered bevaciz ...... rat corneal neovacularization.
@nl
type
label
Topically administered bevaciz ...... rat corneal neovacularization.
@en
Topically administered bevaciz ...... rat corneal neovacularization.
@nl
prefLabel
Topically administered bevaciz ...... rat corneal neovacularization.
@en
Topically administered bevaciz ...... rat corneal neovacularization.
@nl
P2093
P2860
P1476
Topically administered bevaciz ...... rat corneal neovacularization.
@en
P2093
Eun-Soon Kim
Hungwon Tchah
Myoung Joon Kim
P2860
P304
P356
10.3980/J.ISSN.2222-3959.2013.05.06
P577
2013-10-18T00:00:00Z